GeneDx (WGSWW) Competitors $0.11 -0.01 (-10.95%) As of 03:02 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsShort InterestTrendsBuy This Stock WGSWW vs. ACONW, BTSGU, BFRGW, CCLDO, EUDAW, BEATW, LFMDP, LIFWZ, LIFWW, and ONMDWShould you be buying GeneDx stock or one of its competitors? The main competitors of GeneDx include Aclarion (ACONW), BrightSpring Health Services (BTSGU), Bullfrog AI (BFRGW), CareCloud (CCLDO), EUDA Health (EUDAW), HeartBeam (BEATW), LifeMD (LFMDP), MSP Recovery (LIFWZ), MSP Recovery (LIFWW), and OneMedNet (ONMDW). These companies are all part of the "health information services" industry. GeneDx vs. Its Competitors Aclarion BrightSpring Health Services Bullfrog AI CareCloud EUDA Health HeartBeam LifeMD MSP Recovery MSP Recovery OneMedNet Aclarion (NASDAQ:ACONW) and GeneDx (NASDAQ:WGSWW) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, earnings, dividends, media sentiment, institutional ownership, valuation and profitability. Does the media favor ACONW or WGSWW? In the previous week, Aclarion and Aclarion both had 1 articles in the media. Aclarion's average media sentiment score of 1.88 equaled GeneDx'saverage media sentiment score. Company Overall Sentiment Aclarion Very Positive GeneDx Very Positive Which has preferable valuation & earnings, ACONW or WGSWW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAclarion$54.60KN/AN/AN/AN/AGeneDx$362.32MN/AN/AN/AN/A Is ACONW or WGSWW more profitable? Company Net Margins Return on Equity Return on Assets AclarionN/A N/A N/A GeneDx N/A N/A N/A SummaryGeneDx beats Aclarion on 1 of the 1 factors compared between the two stocks. Get GeneDx News Delivered to You Automatically Sign up to receive the latest news and ratings for WGSWW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart WGSWW vs. The Competition Export to ExcelMetricGeneDxHealth Information Services IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$348.29M$5.68B$9.81BDividend YieldN/A5.90%4.61%4.07%P/E RatioN/A373.3030.6825.56Price / SalesN/A238.63464.10116.64Price / CashN/A47.1438.2159.48Price / BookN/A5.048.996.13Net IncomeN/A-$15.55M$3.25B$264.89M7 Day PerformanceN/A-2.45%4.78%2.67%1 Month PerformanceN/A1.84%6.80%3.11%1 Year PerformanceN/A7.14%30.61%25.14% GeneDx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)WGSWWGeneDxN/A$0.11-11.0%N/A+302.6%$0.00$362.32M0.001,000ACONWAclarionN/A$0.03-2.2%N/AN/A$0.00$54.60K0.007BTSGUBrightSpring Health ServicesN/A$70.60+2.6%N/A+69.0%$0.00$11.86B0.0035,000Positive NewsShort Interest ↓Gap UpBFRGWBullfrog AIN/A$0.52+3.1%N/A+29.5%$0.00N/A0.002Gap UpCCLDOCareCloudN/A$20.43+1.1%N/A+73.9%$0.00$112.51M0.004,100Short Interest ↓EUDAWEUDA HealthN/A$0.10-29.3%N/A-33.6%$0.00$4.01M0.00150Gap DownBEATWHeartBeamN/A$0.31+10.7%N/A-48.2%$0.00N/A0.005Gap DownLFMDPLifeMDN/A$24.18-0.3%N/A+9.6%$0.00$234.01M0.00230Short Interest ↓LIFWZMSP RecoveryN/A$0.02flatN/AN/A$0.00$10.73M0.0088LIFWWMSP RecoveryN/A$0.00+5.0%N/A-37.5%$0.00$10.73M0.0088Gap DownONMDWOneMedNetN/A$0.03+19.7%N/A-48.4%$0.00$532K0.0020Positive NewsGap Down Related Companies and Tools Related Companies Aclarion Alternatives BrightSpring Health Services Alternatives Bullfrog AI Alternatives CareCloud Alternatives EUDA Health Alternatives HeartBeam Alternatives LifeMD Alternatives MSP Recovery Alternatives MSP Recovery Alternatives OneMedNet Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:WGSWW) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GeneDx Holdings Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share GeneDx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access